
New Zealand Approves MDMA for PTSD Treatment
New Zealand's drug regulator has approved the use of MDMA, commonly known as the party drug, for treating severe PTSD, with two psychiatrists authorized to prescribe it.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (84/100)Sources
New Zealand drugs regulator approves use of MDMA to treat severe PTSD
New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve the party drug for use in treating PTSD, following Australia in 2023. Continue reading...
By Agence France-Presse
Read full article →New Zealand approves use of party drug MDMA to treat trauma - The Straits Times
New Zealand approves use of party drug MDMA to treat trauma The Straits Times
Read full article →Party Drug MDMA Approved By New Zealand To Treat Trauma
Two psychiatrists in New Zealand won approval Friday to prescribe pharmaceutical-grade MDMA to sufferers of severe post-traumatic stress disorder.
Read full article →Party drug MDMA gets official approval as PTSD treatment
MDMA is a psychoactive drug used recreationally, but now it can be prescribed for recovery from post-traumatic stress disorder.
Read full article →Two psychiatrists approved to prescribe MDMA for PTSD treatment in New Zealand
Medsafe allows pair to provide pharmaceutical-grade MDMA to patients in their clinics.
By Julia Gabel
Read full article →New Zealand approves use of party drug MDMA to treat trauma
New Zealand approves use of party drug MDMA to treat trauma
Read full article →New Zealand approves MDMA for PTSD treatment - The Copenhagen Post
New Zealand approves MDMA for PTSD treatment The Copenhagen Post
Read full article →


